This is the eighth session of PhD Plus Commercialization skills series
How might the funding landscape for the commercialization of science be different from that for other startup companies? What are the differences among angel investors, seed funds, venture capitalists? Not to mention, what different types of capital can these individuals and organizations provide? Joining us today to help answer these questions will be Bob Creeden, Managing Director of the UVA LVG Seed Fund and New Ventures.
David Touve, Senior Director, Applied Innovations and New Ventures, Batten Institute, Darden School of Business
Register here by Friday, Jan 28